Usana Health Sciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Usana Health Sciences Inc in the second quarter 2026?
Usana Health Sciences Inc recorded a cumulative net loss of $-29 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -5.49%.

Within the Legal Cannabis industry 5 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2175 to 2223.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Equity Change	-0.9 %	2.6 %	0.19 %	-0.94 %	-
Y / Y Net Income Change	-	-25.09 %	-	-	0.12 %
Net Income (TTM) in Millions	-29	9	11	18	35
Return On Equity (TTM)	-5.49 %	1.71 %	2.16 %	3.31 %	6.55 %
USNA's Total Ranking	# 2223	# 2175	# 1931	# 1929	# 1563
Equity (TTM) in Millions	526	544	533	528	531
Seq. Equity Change	-3.17 %	1.96 %	0.95 %	-0.56 %	0.25 %
Seq. Net Income Change	-	-	-	-	12.42 %

Back to USNA Management Effectiveness >> USNA's 5 Years Annual ROE >> Compare USNA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 6
Sector	# 86
Overall	# 2223

Return On Equity Statistics
High	Average	Low
39.75 %	24.65 %	-5.49 %
(Jun 29 2013)		(Jul 04 2026)

USNA Annual Return On Equity	(Jan 03 2026) 2025	(Dec 28 2024) 2023	(Dec 31 2022) 2022	(Jan 02 2021) 2020	(Dec 28 2019) 2019
Total Equity in Millions	533	532	434	442	352
Y / Y Equity Change	0.19 %	22.47 %	-1.63 %	25.57 %	-10.08 %
Net Income in Millions	11	42	69	125	101
Y / Y Net Income Change	-72.71 %	-39.35 %	-44.37 %	24.01 %	-20.36 %
Return On Equity	2.15 %	7.9 %	15.96 %	28.23 %	28.58 %

Back to USNA Management Effectiveness >> USNA's 5 Years Annual ROE >> Compare USNA ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 2.15 %, due to deterioration of net income.

More Return On Equity Ratios
Legal Cannabis Industry Roe Trends and Statistics
Consumer Non Cyclical Sector Return On Equity Statistics
USNA's' Return on Equity at Yahoo Finance
USNA's Roe Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for USNA's Competitors
Subscribers only: Roe for Usana Health Sciences Inc 's Suppliers
Subscribers only: Return On Equity for USNA's Customers

Companies with similar Return On Equity at Jul 04 2026, within Consumer Non Cyclical Sector

ROE

Date modified: 2026-09-26T07:14:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.